Radiation Dose Management Market

Radiation Dose Management Market Overview

The global Radiation Dose Management Market size was valued at USD 488.98 million in 2024 and is predicted to reach USD 1080.94 million by 2030 with a CAGR of 14.1% from 2025-2030.

Several factors driving the market growth including rising chronic diseases and the integration of advance technologies. However, high initial investment and ongoing implementation of radiation dose management solutions are restraining the market growth. On the contrary, the integration of Electronic Health Records and Health Information Systems enhances radiation dose management by enhancing patient safety, streamlining healthcare efficiency and reducing unnecessary repeat imaging through comprehensive access to medical histories and radiation dose records.

Moreover, the presence of prominent market players in radiation dose management Canon including Philips Healthcare, Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Lumitron Technologies and others are adopting various market strategies such as collaboration and product launches to enhance market growth in the region.

Rising Chronic Diseases Fuel the Market Growth

The increase in chronic diseases due to the aging population, inactive way of life, poor diets and also changes in the environment drive the growth of the radiation dosage administration market. According to the World Health Organization report, the highest number of NCD deaths was due to cardiovascular diseases, responsible for 17.9 million deaths per year followed by cancers, chronic respiratory diseases, and diabetes.

Integration of advance technologies Drive Market Growth

The integration of artificial intelligence (AI), machine learning (ML) and internet of things (IoT) technology that reduces the risk of radiation exposure to patients are driving the growth of the market. In May 2023, for instance, Philips Introduced CT-3500, an AI-enabled CT system to expedite routine radiology and high-volume imaging. The launch provides cutting-edge artificial intelligence capabilities to help streamline the workflow of radiology departments, an evolution that allows optimization in radiation dose management as imaging exams grow more accurate.

High Costs and Implementation Challenges Restrain Market Growth

The high up-front investment and operating expenses for staff and sustainability for the radiation dose management market solutions are identified as major barriers to market growth and particularly impactful in cost-sensitive environments. 

EHR and HIS Integration Transforming Radiation Dose Management

Integration of Electronic Health Records and Health Information Systems presents significant opportunities for the radiation dose management by improving patient safety and improving healthcare efficiency. This integration enables comprehensive access to patient medical histories including previous imaging studies and associated radiation doses, enabling informed clinical decisions and reducing unnecessary repeat imaging. 

As an example, a partnership of six Ontario healthcare organizations known collectively as the Georgian Bay Information Network (GBIN) announced content of the eNautilus project in September 2023 to improve its utilization of Oracle Health's electronic health records (EHRs). The initiative is focused on expanding services to include sophisticated clinical operations, improved drug administration, and specialized oncology and other clinical support services. This is expected to improve patient safety, enable better coordination of care, and reduce administrative workloads across GBIN’s 15 hospitals. 

Market Segmentation and Scopes of Study

The radiation dose management market is segmented on the basis of type, imaging modality, applications, end-user, and region. On the basis of type, the market is divided into software and service. On the basis of imaging modality, the market is classified into radiography, tomography, nuclear imaging and interventional imaging. On basis of application the market is divided into cardiology, neurology, oncology and orthopaedics. On the basis of end-user, it can be segmented into hospitals, ambulatory surgery centers, diagnostic centers, and others. Geographic breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America shares the major share in radiation dose management industry trends and is projected to retain its share during the forecast period. This is owing to numerous reasons ranging from a rise in medical imaging systems and Computed Tomography (CT) scans in the healthcare sectors especially in the nations such as the U.S. and Canada to provide a remedy against the rising anxiety of chronic disease such as lung cancer and blood cancer in the region. According to the report presented by Lung Cancer Research Foundation, 238,340 people are diagnosed with lung cancer in the year 2023. This heightened awareness spurred a growing demand for radiation dose management among individual, to manage and diagnose such health conditions.

Also, the growing technological innovation in radiation therapy which includes artificial intelligence (AI) and internet of things (IoT), particularly in the U.S. and other regional countries for the treatment of chronic diseases such cancer, tuberculosis (TB), and other diseases is driving the growth of the market. For instance, in February 2023, Lumitron Technologies launched its HyperVIEW EBCS (Extremely Bright Compton Source) x-ray technology with AI feature. This accelerator technology generates electron beams to enable the development of a range of next-generation cancer treatments using electron FLASH radiotherapy.

The radiation dose management industry in Asia-Pacific is estimated to be growing steadily with China government bodies working in coordination with market players to provide an increase in manufacturing demand of radiotherapy equipment’s for healthcare treatment in this region. For example, in March 2023 China National Pharmaceutical Group Corp (Sinopharm) partnered with the Swedish medical equipment manufacturer Elekta to build a joint venture for local manufacturing of radiotherapy equipment in China. This collaboration is a major advancement in radiation dose management in China, and the joint venture will benefit the manufacturing and supply of advanced radiotherapy devices in China.

Moreover, the presence of prominent market players in radiation dose management Canon Inc., Fujifilm holdings incorporation, and others. These firms are adopting several market strategies, including collaboration and product launch, to elevate market growth in the region. And these changes are expected to drive the market demand during the forecast period. For example, in July 2022 Canon Medical Systems Corporation introduced first CT scanner called the Aquilion Exceed LB that helps clinicians with advanced radiation dose monitoring for medical imaging. This innovation addresses important issues pertaining to RDM targeting the improvement of patient safety through optimized dose exposure in diagnostic procedures. 

Competitive Landscape

The radiation dose management industry comprises various market players including Landauer, Canon Inc., Sectra AB, INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Fujifilm Holdings Corporation, QAELUM NV, and others. These market players are adopting various strategies such as product launch and collaboration to maintain their dominance in the radiation dose management market. 

In December 2024, Canon released two CT systems powered by AI, an advancement in medical imaging technology. It uses state-of-the-art AI technology to improve precision and reduce radiation exposure on CT scans, and is expected to promote related developments in the industry. 

Also in November 2023, Qaelum NV also partnered with Philips Forge for Advance Radiation Dose Management. The partnership meets a market need for innovative and integrated radiation dose management solutions and combines the resources of Qaelum NV and Philips to enable innovation, drive acuity, and improve patient safety across the wider market.

In addition, in September 2023, INFINITT Healthcare Co. Ltd., entered into a partnership agreement with Hamamatsu Corporation, one of the largest manufacturers of devices that generate and measure visible, infrared and ultraviolet light, that will promote Hamamatsu whole slide scanners (NanoZoomers) and INFINITT Digital Pathology Solution (IDPS) to its U.S. customers.

Key Benefits

• The report provides quantitative analysis and estimations of the radiation dose management market from 2025 to 2030, which assists in identifying the prevailing market opportunities.

• The study comprises a deep dive analysis of the radiation dose management market including the current and future trends to depict prevalent investment pockets in the market.

• Information related to key drivers, restraints, and opportunities and their impact on the radiation dose management market is provided in the report. 

• Competitive analysis of the players, along with their market share is provided in the report.

• SWOT analysis and Porters Five Forces model is elaborated in the study.

• Value chain analysis in the market study provides a clear picture of roles of stakeholders.

Radiation Dose Management Market Key Segments

By Type

• Software

• Services

By Imaging Modality

• Radiography

• Tomography

• Nuclear Imaging 

• Interventional Imaging 

By Application

• Cardiology

• Neurology

• Oncology 

• Orthopaedics

By End User

• Hospitals

• Ambulatory Surgery Centers

• Diagnostic Centers

• Others 

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • The UK

  • Germany

  • France        

  • Italy        

  • Spain        

  • Denmark        

  • Netherlands        

  • Finland        

  • Sweden        

  • Norway        

  • Russia        

  • Rest of Europe    

• Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  • Taiwan

  • Thailand

  • Rest of Asia Pacific

• Rest of the World

  • Latin America

  • Middle East

  • Africa

Key Players

• Landauer

• Canon Inc.

• Sectra AB

• INFINITT Healthcare Co. Ltd.

• Bayer AG

• PACSHealth LLC

• Koninklijke Philips N.V.

• GE Healthcare

• Fujifilm Holdings Corporation

• QAELUM NV

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2024	USD 488.98 Million
Revenue Forecast in 2030	USD 1080.94 Million
Growth Rate	CAGR of 14.1% from 2025 to 2030
Analysis Period	2024–2030
Base Year Considered	2024
Forecast Period	2025–2030
Market Size Estimation	Million (USD)
Growth Factors	Rising prevalence of chronic diseases is propelling the market expansion. Integration of advance technologies such as artificial intelligence (AI) and machine learning (ML) further boosts the market.
Countries Covered	28
Companies Profiled	10
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.